NBO Pharma Inc., 2026-01-22
An SEC Form D private-offering notice from Bedford, NY, a $7,640,217 filer-stated offering target in Biotech. Filed 2026-01-22. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical-stage pharmaceutical company developing an intranasal octreotide formulation to treat Idiopathic Intracranial Hypertension, in Phase 2 trials with US and EU orphan drug designations.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Vleyr Technologies Inc., 2026-01-22, $3M, Valley Stream, NY
- Windgap Medical, Inc., 2026-01-26, $17.2M, Watertown, MA
- Show Biz, Its Just Show Biz Ltd Liability Co, 2026-01-22, $4M, New York, NY
- Eletala Enterprises Inc, 2026-01-22, $10M, Wilmington, DE
- Intergalactic Data Labs, Inc., 2026-01-22, $4M, New York, NY
- PICO HOLDINGS, INC., 2026-01-22, $8M, Sacramento, CA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.